Can-Fite BioPharma Ltd. (TLV: CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA2.900
0.00 (0.00%)
Oct 14, 2024, 5:24 PM IDT
Can-Fite BioPharma Employees
Can-Fite BioPharma had 8 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
313.92K ILS
Profits / Employee
-3.47M ILS
Market Cap
63.37M
Employees Chart
Can-Fite BioPharma News
- 6 days ago - Can-Fite stock rallies 17% on FDA orphan drug designation - Seeking Alpha
- 7 days ago - FDA Grants Orphan Drug Designation to Can-Fite's Namodenoson for Pancreatic Cancer - GlobeNewsWire
- 4 weeks ago - Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health - GlobeNewsWire
- 6 weeks ago - Can-Fite BioPharma files to sell 1.77B shares of common stock for holders - Seeking Alpha
- 6 weeks ago - Can-Fite Biopharma GAAP EPS of $0.00, revenue of $0.32M - Seeking Alpha
- 6 weeks ago - Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical Studies - GlobeNewsWire
- 2 months ago - OS Therapies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 2 months ago - Can-Fite Announces Exercise of Warrants for Approximately $5.0 Million in Gross Proceeds - GlobeNewsWire